{"id":21924,"date":"2019-11-25T16:33:01","date_gmt":"2019-11-25T15:33:01","guid":{"rendered":"https:\/\/www.oafifoundation.com\/?p=21924"},"modified":"2023-05-11T20:46:32","modified_gmt":"2023-05-11T18:46:32","slug":"manifest-press-note-against-possible-sysadoas-definancing","status":"publish","type":"post","link":"https:\/\/www.oafifoundation.com\/en\/manifest-press-note-against-possible-sysadoas-definancing\/","title":{"rendered":"Press Release Against The Possible Definancing of SYSADOAs"},"content":{"rendered":"\n

On January 23rd, OAFI Foundation together with AECOSAR, Alianza General de Pacientes<\/a>, Conartritis, el Foro Espa\u00f1ol de Pacientes <\/a>and the Liga Reumatoloxica Galega<\/a>, organized a press conference in Madrid, to present the Joint Manifesto to explain the positioning of these entities regarding the possible defunding of SYSADOAs drugs for the treatment of Osteoarthritis.<\/p>\n\n\n\n

The event, which was held at the headquarters of SEFAC (Spanish Society of Family and Community Pharmacy), was attended by Dr. Jos\u00e9 Lu\u00eds Baquero as representative of Foro Espa\u00f1ol de Pacientes , by Maria Antonia Robles, President of AECOSAR, Dr. Josep Verg\u00e9s as President of OAFI and Ms. Navidad S\u00e1nchez, Vice President of SEFAC Madrid. As specialists who participated in the “Document on the appropriate use of oral SYSADOAs in the arthritic patient in the field of primary care”<\/strong> were Dr. Pilar Rodr\u00edguez Ledo, vice president of the SEMG (Spanish Society of General Practitioners and Family), Dr. Jordi Monfort, Head of the Rheumatology Service of the Hospital del Mar in Barcelona and Prof. Antonio Garc\u00eda, Clinical Pharmacologist, President. of the Instituto Te\u00f3filo Hernando de Madrid. <\/p>\n\n\n\n

In addition, the event was attended by Ma Teresa Verg\u00e9s, Director of the Patient and Volunteering Area of the OAFI Foundation, who introduced different patients from different parts of Spain, providing their testimony as OA patients and users of SYSADOAs. Also present was Dr. Pedro Guill\u00e9n of the Cemtro Clinic, who wanted to leave his testimony through a video where he explained his reasons for the use of these drugs. <\/p>\n\n\n\n

In the press conference, it was presented the will to dialogue with the Ministry of Health to reach an agreement, since the organizations mentioned consider that it would be “a serious prejudice for thousands of people, as well as an attack on the right to universal health and basic rights of very vulnerable population groups”. <\/p>\n\n\n\n

The press conference was followed with great interest by different media outlets. Here is a sample of some of them: <\/p>\n\n\n\n

Correo Farmac\u00e9utico<\/a><\/p>\n\n\n\n

La Vanguardia<\/a><\/p>\n\n\n\n

EuropaPress<\/a><\/p>\n\n\n\n

Elcomercio.es<\/a><\/p>\n\n\n\n

65ymas.com<\/a><\/p>\n\n\n\n

Consalud.es<\/a><\/p>\n\n\n\n

La Raz\u00f3n<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

On January 23rd, OAFI Foundation together with AECOSAR, Alianza General de Pacientes, Conartritis, el Foro Espa\u00f1ol de Pacientes and the Liga Reumatoloxica Galega, organized a press conference in Madrid, to present the Joint Manifesto to explain the positioning of these entities regarding the possible defunding of SYSADOAs drugs for the treatment of Osteoarthritis. The event, which was […]<\/p>\n","protected":false},"author":1,"featured_media":30160,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[515,563],"tags":[],"class_list":["post-21924","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-oafi","category-osteoartritis"],"_links":{"self":[{"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/posts\/21924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/comments?post=21924"}],"version-history":[{"count":2,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/posts\/21924\/revisions"}],"predecessor-version":[{"id":32283,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/posts\/21924\/revisions\/32283"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/media\/30160"}],"wp:attachment":[{"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/media?parent=21924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/categories?post=21924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oafifoundation.com\/en\/wp-json\/wp\/v2\/tags?post=21924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}